0
No hay productos en el carro de la compra
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Casa > Integrin alpha 3 beta 1

Integrin alpha 3 beta 1

Brief Information

Name:Integrin alpha 3/beta 1
Target Synonym:
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

Por estado del producto :
Por categoría de producto :
Por especies :
Por etiqueta :
Por Conjugado::
Cat. No. Especies Descripción del producto Estructura Pureza Característica
IT1-R53Wb Rat Rat Integrin alpha 3 beta 1 (ITGA3&ITGB1) Heterodimer Protein, His Tag&Tag Free (MALS verified)
IT1-R53Wb-structure
IT1-R53Wb-sds
IT1-H52Wc Human Human Integrin alpha 3 beta 1 (ITGA3&ITGB1) Heterodimer Protein, His Tag&Tag Free (MALS verified)
IT1-H52Wc-structure
IT1-H52Wc-sds
ACRO Quality

Part of Bioactivity data

IT1-H52Wc-SPR
 Integrin alpha 3 beta 1 SPR

Human Laminin 511 Protein, premium grade (Cat. No. LA8-H5283) captured on Protein A Chip can bind Human ITGA3&ITGB1 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT1-H52Wc) with an affinity constant of 30.8 nM as determined in SPR assay (Biacore 8K) (Routinely tested).

IT1-H52Wc-BLI
 Integrin alpha 3 beta 1 BLI

Loaded Human Laminin 511 Protein, premium grade (Cat. No. LA8-H5283) on Protein A Biosensor, can bind Human ITGA3&ITGB1 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT1-H52Wc) with an affinity constant of 8.6 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Synonym Name

Integrin alpha 3 beta 1,ITGA3&ITGB1

Background

Integrin alpha-3/beta-1 is a receptor for fibronectin, laminin, collagen, epiligrin, thrombospondin and CSPG4. Integrin alpha-3/beta-1 provides a docking site for FAP (seprase) at invadopodia plasma membranes in a collagen-dependent manner and hence may participate in the adhesion, formation of invadopodia and matrix degradation processes, promoting cell invasion. Alpha-3/beta-1 may mediate with LGALS3 the stimulation by CSPG4 of endothelial cells migration.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
VAX-014 VAX-014 Phase 1 Clinical Vaxiion Therapeutics Llc Solid tumours Details
VAX-014 VAX-014 Phase 1 Clinical Vaxiion Therapeutics Llc Solid tumours Details

This web search service is supported by Google Inc.

totop
Email
Correo electrónico
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland

Dejar un mensaje